Neursantys stands at the forefront of non-invasive bioelectronics, addressing neuromotor and neurocognitive conditions lacking widespread pharmacological solutions. Our flagship product platform, NEURVESTA, delivers the world’s first restorative neuroplastic treatment for age-related balance decline, a medical condition that is now known to begin as early as age 40 and affect over 70 million people in Canada and the U.S. alone.
| Website | https://neursantys.com |
| Employees | 7 (0 on RocketReach) |
| Founded | 2022 |
| Address | 659 Oak Grove Ave, Menlo Park, California 94025, US |
| Industry | Medical Equipment Manufacturing |
| Keywords | Bioelectronics, Non Invasive Treatments, Neurocognitive Disorders, Neuromodulation, Neurological Conditions, Brain Stimulation, Neurological Devices, Neurological Rehabilitation, Innovative Therapies, Cognitive Enhancement, Medical Devices, Central Nervous System, Peripheral Nervous System |
Looking for a particular Neursantys employee's phone or email?
Neursantys is based in Menlo Park, California.